Site Management/Investigator Payments Featured Articles

31. Say It Loud: Clinical Research Needs New Voices 2/26/2026

    At SCOPE, I caught up with Denali Rose, co-host of the Note to File podcast, to talk about why clinical research still struggles to communicate — and why that has to change. She’s pushing for more honest conversations and new voices across sponsors, sites, and vendors, and while progress is slow, she sees signs the silos are finally starting to crack.

32. Site-Centric First, Patient-Centric Always 2/25/2026

    At the 2026 SCOPE Summit, Boehringer Ingelheim’s Wouter Daniels argued that true patient centricity begins with site centricity. Daniels shared how Boehringer’s engagement efforts have accelerated studies by months and saved millions — proof that patient focus delivers measurable business and operational value.

33. Why Sponsors Should Share KPI Rationale With Sites 2/25/2026

    To build partnerships, foster transparency, and promote shared accountability, Curo Research CEO Amy Bland explains why sponsors need to communicate the utility of KPIs with sites.

34. From Standards To Study Conduct: The Operational Reality Of RBQM 2/22/2026

    Operationalizing risk-based quality management requires early identification of critical-to-quality factors, cross-functional collaboration, integrated systems, and a cultural shift toward proactive, proportionate trial oversight.

35. Joe Dustin: Sites Are Driving Clinical Tech Evolution 2/20/2026

    At SCOPE Summit 2026, Joe Dustin shared why clinical trial sites are emerging as the next drivers of innovation. As sites digitize operations and push back against the burden of sponsor-mandated systems, new models like “bring your own technology” and seamless digital data flow aim to reduce duplication, speed startup, and improve both coordinator and patient experiences.

36. How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together 2/3/2026

    TransCelerate BioPharma's Andy Lee and Janice Change share the lessons they learned bringing disparate voices together for a united purpose.

37. The U.S. Trial Advantage Is Eroding 1/30/2026

    Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

38. Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites 1/27/2026

    Incomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD.

39. What CROs Do Right Isn't Always Obvious To Research Sites 1/26/2026

    CROs are doing many things right. But it's when that right thing is understood — not just executed — that the impact becomes far greater than compliance alone.

40. How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials 1/26/2026

    VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.